Investment17 Mar 2026, 12:38 pm
Persistent Systems Collaborates with NVIDIA to Accelerate Computational Drug Discovery with AI
AI Summary
Persistent Systems Ltd. has partnered with NVIDIA to launch an AI-powered generative molecules and virtual screening solution. This collaboration aims to advance computational drug discovery and improve research outcomes in the Healthcare and Life Sciences industry using Generative AI and advanced analytics. The new solution, GenMolVS, will deliver AI-driven molecular simulations, enabling high-fidelity molecular simulation and virtual screening at scale, and streamlining real-time drug discovery workflows.
Key Highlights
- Persistent Systems and NVIDIA collaborate to accelerate computational drug discovery using AI
- GenMolVS solution to deliver AI-driven molecular simulations for Life Sciences organizations
- High-fidelity molecular simulation and virtual screening at scale for preclinical research
- Production-grade agentic systems for molecular simulation and virtual screening
- Persistent to expand AI and LLM engineering capabilities using NVIDIA AI infrastructure